• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Health Canada licenses Medtronic extended-wear infusion set for insulin delivery

December 12, 2022 By Sean Whooley

Medtronic Extended Wear Infusion Set Insulin Delivery Diabetes
[Image from Medtronic]
Medtronic (NYSE:MDT) Canada announced that Health Canada licensed its Medtronic Extended infusion set for insulin pumps.

The Medtronic Extended Infusion Set is the first and only infusion set labeled for a wear time of up to seven days. The infusion set for delivering insulin from a pump to the body typically requires changing every two to three days.

Its availability covers customers using MiniMed 600 and 700 series pumps. Medtronic developed it in partnership with Convatec Infusion Care.

Medtronic designed its infusion set with advanced materials for reducing insulin preservative loss and maintaining insulin flow. This helps provide stability, doubling the wear time of a typical infusion set. Its proprietary technology includes a new tubing connector for improving insulin’s physical and chemical stability. The connector also enhances the reliability of infusion site performance and reduces the risk of infusion set occlusion.

The system also features an adhesive patch with a layer that helps extend wear time and provide comfort and durability. Medtronic said its Extended reservoir is the only infusion set reservoir tested and cleared for this duration, too. The company launched the set in the U.S. last month.

Medtronic delivers infusion innovation to Canada

Studies demonstrated a 50% decrease in the number of times patients needed to change their infusion set. It also lowered the number of infusion set failures associated with high glucose levels.

Participants said the set was more comfortable than previous sets, and that the longer wear reduced the burden of insulin pump therapy.

“We’re thrilled to deliver this unique innovation in our mission to help ease the burden of living with type 1 diabetes,” said Laura Cameron, senior director of endocrinology at Medtronic Canada. “The Medtronic Extended infusion set will help increase convenience, simplicity and sustainability, and our insulin pump customers can keep the infusion sites they prefer working longer. With all the daily decisions and actions required to manage this chronic condition, we’re pleased to have an option that can help make life a little easier.”

Medtronic expects to make the Extended infusion set available in Canada in spring 2023.

“When patients first begin using a pump, doctors and other healthcare providers reinforce the need to change their infusion set every two to three days to limit the risk of infection and other safety concerns. For many people, this means scheduling life around infusion set changes, which may not be at the most convenient times― turning around as you are headed out the door when you suddenly remember to change your infusion set or adding a few minutes to a tired child’s bedtime routine with an infusion set change,” said Dr. Robert Vigersky, CMO of Medtronic Diabetes. “With the Medtronic Extended infusion set, these life interruptions are reduced with an innovation that doubles the wear.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: Health Canada, Medtronic

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS